Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Central Hypothyroidism and Adjusted Thyroxine Dose Study (CHATS)
2004-005184-15Phase 4Completed
- Sponsor
- The Christie
- Start
- Apr 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of levothyroxine sodium in central hypothyroidism (CeH) and hypopituitarism, sponsored by The Christie. Primary endpoints: Quality of life change (SF-36) and Quality of life change (EQ-5D). Started Apr 2005; status: completed.
02
Drugs
levothyroxine sodium
03
Conditions
central hypothyroidism (CeH)hypopituitarism
Beyond the preview
Go deeper on 2004-005184-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-005184-15.